[Experimental chemotherapy against human esophageal carcinoma xenografts with TS-1, cisplatin and docetaxel]. 2006

Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
Biomedical Laboratory, Kitasato Institute Hospital.

Three strains of human esophageal carcinoma xenografts established in our institution were tested against combination chemotherapy in vivo and in vitro. TS-1 plus cisplatin (CDDP) was shown to be an effective combination against two carcinoma strains of moderately-differentiated type. Determination of the thymidylate synthase (TS) demonstrated a higher inhibition of the enzyme by adding CDDP to 5-FU, suggesting biochemical modulation. The remaining strain of poorly-differentiated type was resistant to the combination and an attempt was made to add docetaxel (DTX) to show that the three-drug combination was effective against the strain. Combination chemotherapy including TS-1 and CDDP thus appears to be useful treatment choice for esophageal carcinoma.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D010094 Oxonic Acid Antagonist of urate oxidase. Oteracil
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207

Related Publications

Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
September 2018, Anticancer research,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
January 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
January 2024, Oncology,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
October 2016, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
February 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
June 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
July 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
April 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
November 2013, Cancer science,
Takaya Yamada, and Asako Masuda, and Miki Tongu, and Osamu Hiraku, and Tadahiro Etou, and Ken Sasaki, and Koichiro Atsuda, and Seijiro Morinaga, and Tatsuo Suzuki, and Yukio Suzuki, and Masayoshi Osaku, and Takeshi Miyagawa, and Fumiki Asanuma, and Yoshinori Yamada
May 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!